273092 Michiganís experience with the SUID Case Registry

Monday, October 29, 2012 : 11:24 AM - 11:42 AM

Shannon Stotenbur-Wing, MSW , Center for Child and Family Health, Michigan Public Health Institute, Okemos, MI
SUID Case Registry team has a three-prong approach to SUID case identification. Local Child Death Review (CDR) teams review the case within 90 days. Often these cases are reviewed at multiple meetings as they await autopsy results. After review, local CDR coordinators enter the case and the Michigan SUID Coordinator conducts a quality check for every case to ensure completeness. In Michigan, 140 sleep related infant deaths were reviewed in 2010 and 139 in 2011 as a part of the SUID Case Registry pilot program. In 58% of the cases reviewed in 2010, blankets were present in the crib, bassinet or playpen at the time of the death. Michigan found that in over 70% of SUID cases a full scene investigation was completed. This has allowed for detailed information to be collected at the scene and then transferred to the medical examiner for their review prior to determining cause and manner of death for SUID cases. As a result of the SUID Case Registry Pilot Program, Michigan continues to pursue a statewide prevention campaign to address the risks of suffocation when babies are not placed to sleep in a safe environment.

Learning Objectives:
Describe at least two strategies used by Michiganís SUID Case Registry pilot program to improve SUID case investigation and create state-wide SUID prevention initiatives

Keywords: SIDS, Maternal and Child Health

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have worked in the Child Protection Child Death arena for the past 15 years. As the Director of the Center for Child and Family Health I manage the operations for the Michigan Child Death Review Program as well as the Sudden Unexpected Infant Death Case Registry Project.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.